Products

Point of Care Anticoagulation Software

Point of Care Anticoagulation Software

Related Content

EMVision's First Responder device aims to fundamentally transform stroke and traumatic brain injury outcomes for all patients
News | Radiology Imaging
Australian Medtech EMVision Unveils Backpack-Sized Brain Scanner to Empower First Responders

July 23, 2024 — EMVision, an Australian medical device company focused on the development and commercialization of ...

Time July 23, 2024
arrow
Medtronic has reported preliminary findings of the first and only head-to-head trial comparing standard-of-care CT-guided biopsy with electromagnetic navigation bronchoscopy (ENB) for the diagnosis of lung nodules.
News | Radiology Business
Medtronic Announces Positive Preliminary Data from VERITAS Clinical Study at American Thoracic Society, ATS 2024

May 22, 2024 — Medtronic has announced new preliminary data from the VERITAS clinical study using its ILLUMISITE ...

Time May 22, 2024
arrow
Lantheus announced that the U.S. Food and Drug Adminstration (FDA) has approved DEFINITY (Perflutren Lipid Microsphere) as an ultrasound enhancing agent for use in pediatric patients with suboptimal echocardiograms, including those who have undergone heart transplant, or have Kawasaki disease or a congenital cardiovascular anomaly.
News | FDA
Lantheus Announces the FDA Approval of DEFINITY as Ultrasound Enhancing Agent for Use in Certain Pediatric Cardiovascular Patients

March 6, 2024 — Lantheus Holdings, Inc. (Lantheus), a radiopharmaceutical company, has announced that the U.S. Food and ...

Time March 06, 2024
arrow
Proscia, a software company accelerating the transformation to digital pathology, has announced its receipt of 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its Concentriq AP-Dx for the purpose of primary diagnosis.
News | FDA
Proscia Receives FDA Clearance for Digital Pathology Software Solution

February 12, 2024 — Proscia, a leading provider of digital and computational pathology solutions, has received 510(k) ...

Time February 12, 2024
arrow
Attendees at RSNA 2023 were among the first to learn about the digital health leader’s latest clinical advancements and international expansion
News | Artificial Intelligence
RapidAI Announces a Series of Industry Firsts – Unique Rapid Edge Cloud Platform, Breakthrough AI Non-Contrast CT Suite, International Expansion in Japan

December 11, 2023 — RapidAI, a global leader in developing artificial intelligence (AI) and technology workflow ...

Time December 11, 2023
arrow
AI-powered NeuroShield automatically quantifies brain volumes using MRI data – the first of its kind with the capability to provide ethnicity-specific reference ranges
News | Artificial Intelligence
Heuron Showcasing Neuro AI Solutions and Presenting Abstract on AI Solutions for Stroke at RSNA23

November 21, 2023 — Heuron, a medical AI (artificial intelligence) imaging software solution company, under the ...

Time November 21, 2023
arrow
Further enhancing comprehensive trauma care solution
News | Artificial Intelligence
RapidAI Receives FDA Clearance of AI Module for Detection of Hemispheric Subdural Hematomas

November 9, 2023 — RapidAI, a global leader in developing artificial intelligence (AI) and technology workflow solutions ...

Time November 09, 2023
arrow
Medical imaging artificial intelligence (AI) company Annalise.ai has announced that results from a pioneering clinical study, which examined whether its technology improves radiologists’ performance, have been published in the journal European Radiology.
News | Artificial Intelligence
Study Shows Annalise Deep Learning System Boosts Radiologist Accuracy and Speed for Head CTs

September 20, 2023 — Medical imaging artificial intelligence (AI) company Annalise.ai has announced that the results ...

Time September 20, 2023
arrow
Study investigated impact of radiographic media contrast shortage on stroke patient scan data
News | Contrast Media
Researchers Discover Contrast Dye Shortage Affected Assessment of Stroke Patients

August 17, 2023 — University of Missouri School of Medicine neurologist Adnan Qureshi, MD recently led a study that ...

Time August 17, 2023
arrow
News | SNMMI
Prostate Cancer Treatment Study at SNMMI 2023 Finds Improved Patient Outcomes with Personalized Dosing

June 29, 2023 — A study presented this week during the 2023 Society of Nuclear Medicine and Molecular Imaging (SNMMI) ...

Time June 29, 2023
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now